# Observational carcinoma studies recruiting: 707 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 707 trials that are observational for carcinoma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational carcinoma studies: 707 rows for $35.35, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 19 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/carcinoma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 707
- Recruiting or not yet: 707
- Read on: November 19, 2026

## Trials

The 25 newest of 707, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946445 | Assessment of Patient Radiation Exposure and Development of Diagnostic Reference Levels(DRLs) Standards for Endoscopic Retrograde... | Institute of Liver and Biliary Sciences, India | Observational | Not yet recruiting | Choledocholithiasis, Biliary Stricture, Chronic Pancreatitis, Periampullary Carcinoma, Cholangiocar.... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946445) |
| November 17, 2026 | NCT07942025 | 90Y-SIRT as Conversion Therapy for Unresectable Hepatocellular Carcinoma | Beijing Tsinghua Chang Gung Hospital | Observational | Not yet recruiting | Hepatocellular Carcinoma (HCC) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942025) |
| November 17, 2026 | NCT07941830 | AI-Based Anatomy Recognition in Minimally Invasive Kidney Surgery | Chinese PLA General Hospital | Observational | Not yet recruiting | Kidney (Renal Cell) Cancer, Ureteropelvic Junction Obstruction, Upper Urinary Tract Carcinoma | 1,700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941830) |
| November 16, 2026 | NCT07939997 | ctDNA Observational Biomarker Validation Study for Evaluation of Esophageal Squamous Cell Carcinoma | University of Colorado, Denver | Observational | Not yet recruiting | Esophageal Squamous Cell Carcinoma (ESCC) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939997) |
| November 16, 2026 | NCT07938385 | Characterisation of Immunological and Molecular Changes Evolving in Patients Undergoing Radiotherapy (CHIMERA) | Royal Marsden NHS Foundation Trust | Observational | Recruiting | Impact of the Immune Cell Repertoire on the Therapeutic Index of Radiotherapy, The Need for Serum Markers of... | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938385) |
| November 9, 2026 | NCT07926308 | Real-world Outcome of Zongertinib in Japan (J-HERZ) | Boehringer Ingelheim | Observational | Not yet recruiting | Non-small Cell Lung Cancer | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926308) |
| November 6, 2026 | NCT07921888 | Patient-Specific MRD Liquid Biopsy in Resected NSCLC: Plasma and Bronchial Washing ctDNA | Sponsor not shown (see the record) | Observational | Recruiting | Non-Small Cell Lung Cancer, Minimal Residual Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07921888) |
| November 5, 2026 | NCT07918755 | Development and Validation of a Biopsy Decision Model for Nasopharyngeal Carcinoma Based on Serological Markers and Endoscopic Features | Zhongshan People's Hospital, Guangdong, China | Observational | Not yet recruiting | Nasopharyngeal Carcinoma (NPC) | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918755) |
| November 4, 2026 | NCT07914972 | Treatment Pattern and Patient Outcomes Among Stage I-II Unresected NSCLC Patients | AstraZeneca | Observational | Not yet recruiting | Non-small Cell Lung Cancer, NSCLC, Stage I-II Unresected NSCLC | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914972) |
| November 4, 2026 | NCT07914764 | 68Ga-labeled Cholecystokinin Receptor (CCK2R) Targeted Molecular Probes in Early Tumor Diagnosis | Nanjing First Hospital, Nanjing Medical University | Observational | Recruiting | Medullary Thyroid Carcinoma, Small Cell Lung Cancer ( SCLC ), Gastric Adenocarcinoma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914764) |
| November 2, 2026 | NCT07911267 | Development and Utilization of an Integrated Clinical Genomic Database | Samsung Medical Center | Observational | Recruiting | Gastric Cancer, Colorectal Cancer, Lung Cancer (NSCLC), Liver Cancer, Pancreatic Cancer | 118,750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911267) |
| November 2, 2026 | NCT07909343 | Patient Needs and Preferences for NSCL Cancer Treatment Monitoring | European Institute of Oncology | Observational | Recruiting | Lung Cancer (NSCLC) | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909343) |
| October 30, 2026 | NCT07905937 | Exploration of Whole-Brain Radiotherapy Combined With PD-1 Inhibitors on Brain Injury | Guizhou Medical University | Observational | Recruiting | Small Cell Lung Cancer ( SCLC ), Brain Injury | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07905937) |
| October 29, 2026 | NCT07904494 | Immune-Related Adverse Events and Clinical Outcomes of First-Line Immunotherapy in Egyptian Patients With Unresectable Hepatocellular... | Assiut University | Observational | Not yet recruiting | Hepatocellular Carcinoma, Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Non-Resectable, Hepatocellular... | 294 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904494) |
| October 29, 2026 | NCT07904013 | Impact of a Radiologic and Immunologic Signature on Cerebral Efficacy of Treatments in Lung Cancers With Brain Metastasis | University Hospital, Bordeaux | Observational | Not yet recruiting | Carcinoma, Non-Small-Cell Lung, Brain Neoplasms, Neoplasm Metastasis | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904013) |
| October 28, 2026 | NCT07901569 | Habitat Analysis of Tumor Thrombus for Vena Cava Wall Invasion in Renal Cell Carcinoma | Sponsor not shown (see the record) | Observational | Not yet recruiting | Carcinoma, Renal Cell, Inferior Vena Cava Tumor Thrombus | 273 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901569) |
| October 28, 2026 | NCT07900581 | Analysis of Whole Exome and Transcriptome Sequencing to Identify Prognostic Biomarkers in Patients With Non-Small Cell Lung Cancer (NSCLC) | Hellenic Cooperative Oncology Group | Observational | Recruiting | Non-small Cell Lung Cancer (NSCLC) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900581) |
| October 22, 2026 | NCT07888374 | Urinary Cell-Free DNA Liquid Biopsy for Urothelial Cancer Diagnosis and Origin Identification | Ruijin Hospital | Observational | Recruiting | Urothelial Carcinoma (UC), Upper Tract Urothelial Carcinoma, Bladder Cancer | 477 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888374) |
| October 19, 2026 | NCT07880106 | Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast Cancer | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Observational | Recruiting | Lung Cancer Non-small Cell, Colorectal Cancer, Stomach Cancer, Hepatocellular Carcinoma, Breast Cancer | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880106) |
| October 15, 2026 | NCT07874542 | Plasma DNA Methylation for Preoperative Classification of Renal Masses | RenJi Hospital | Observational | Recruiting | Renal Cell Carcinoma, Benign Renal Mass | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874542) |
| October 7, 2026 | NCT07863258 | STRATHEP: AI-Driven Treatment Stratification for Advanced Hepatocellular Carcinoma | Universitaire Ziekenhuizen KU Leuven | Observational | Recruiting | Hepatocellular Carcinoma (HCC) | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07863258) |
| October 5, 2026 | NCT07858630 | Radiotherapy Target Volume Delineation in Locally Advanced Esophageal Cancer in the Immunotherapy Era | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Observational | Recruiting | Esophageal Squamous Cell Carcinoma | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07858630) |
| October 2, 2026 | NCT07855926 | Perioperative Systemic Therapies in Muscle-Invasive Bladder Cancer (GUARDIANS) | LMU Klinikum | Observational | Recruiting | Urothelial Carcinoma of the Bladder, Muscle Invasive Bladder Cancer (MIBC) | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855926) |
| October 2, 2026 | NCT07854769 | Blood Testing to Detect Cancer Recurrence in Patients With Early-Stage Non-Small Cell Lung Cancer | Fox Chase Cancer Center | Observational | Not yet recruiting | Non Small Cell Lung Cancer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07854769) |
| October 1, 2026 | NCT07851818 | Screening Psychosocial Distress in Head and Neck Cancer | Hôpital NOVO | Observational | Not yet recruiting | Head and Neck Cancer (H&N) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851818) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 14 |
| Sun Yat-sen University | 13 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 13 |
| Fudan University | 10 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 10 |
| Shanghai Zhongshan Hospital | 9 |
| Tongji Hospital | 9 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 9 |
| Peking University Cancer Hospital & Institute | 8 |
| Nanfang Hospital, Southern Medical University | 8 |
| National Taiwan University Hospital | 8 |
| Assistance Publique - Hôpitaux de Paris | 7 |
| Assiut University | 7 |
| M.D. Anderson Cancer Center | 7 |
| IRCCS San Raffaele | 7 |
| Memorial Sloan Kettering Cancer Center | 6 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 6 |
| Ruijin Hospital | 6 |
| Shanghai Chest Hospital | 6 |
| National Cancer Institute (NCI) | 6 |
| Peking University People's Hospital | 5 |
| Samsung Medical Center | 5 |
| Henan Cancer Hospital | 5 |
| University Hospital, Strasbourg, France | 5 |
| West China Hospital | 5 |

## By country

| Country | Trials |
| --- | --- |
| China | 220 |
| United States | 114 |
| Italy | 75 |
| France | 46 |
| Germany | 25 |
| United Kingdom | 24 |
| South Korea | 19 |
| Spain | 17 |
| Belgium | 13 |
| Netherlands | 13 |
| Taiwan | 13 |
| Japan | 10 |
| Turkey (Türkiye) | 9 |
| Canada | 9 |
| Egypt | 8 |
| Sweden | 8 |
| Austria | 7 |
| Israel | 7 |
| Poland | 5 |
| Denmark | 5 |
| Greece | 4 |
| Switzerland | 4 |
| Australia | 4 |
| Hong Kong | 4 |
| Puerto Rico | 3 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Waste collection companies in the United States](https://specstream.ai/data/businesses/waste-collection-companies/united-states)
- [Pulmonology practices in the United States](https://specstream.ai/data/businesses/pulmonology-practices/united-states)
- [Malaysian restaurants in the United States](https://specstream.ai/data/businesses/malaysian-restaurants/united-states)
- [Fitness equipment wholesalers in the United States](https://specstream.ai/data/businesses/fitness-equipment-wholesalers/united-states)
- [Certification bodies in the United States](https://specstream.ai/data/businesses/certification-bodies/united-states)
- [Abrasives suppliers in the United States](https://specstream.ai/data/businesses/abrasives-suppliers/united-states)
